![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin |
Jaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo |
Cancer Research and Treatment. 2019;51(3):901-909. Published online 2018 October 4 DOI: https://doi.org/10.4143/crt.2018.326 |
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin chemotherapy: retrospective analysis of 142 patients Gemcitabine Plus Cisplatin Versus Gemcitabine Chemotherapy for Advanced Biliary Tract Cancer Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer Clinical outcomes of gemcitabine, cisplatin plus S-1 in patients with advanced biliary tract cancer Gemcitabine Plus Cisplatin Versus Capcitbine Plus Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer Second-Line Therapy of S-1 for Patients with Advanced Biliary Tract Cancer After Failure to Cisplatin Plus Gemcitabine Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort Study |
This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014. |